T. Rowe Price Associates’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.22M | Sell |
|
|||||
|
2025
Q2 | $1.07M | Buy |
|
|||||
|
2025
Q1 | $1.03M | Buy |
|
|||||
|
2024
Q4 | $950K | Buy |
|
|||||
|
2024
Q3 | $1.21M | Buy |
|
|||||
|
2024
Q2 | $994K | Buy |
|
|||||
|
2024
Q1 | $1.14M | Buy |
|
|||||
|
2023
Q4 | $885K | Buy |
|
|||||
|
2023
Q3 | $626K | Buy |
|
|||||
|
2023
Q2 | $580K | Buy |
|
|||||
|
2023
Q1 | $637K | Sell |
|
|||||
|
2022
Q4 | $656K | Buy |
|
|||||
|
2022
Q3 | $443K | Buy |
|
|||||
|
2022
Q2 | $453K | Buy |
|
|||||
|
2022
Q1 | $492K | Buy |
|
|||||
|
2021
Q4 | $412K | Sell |
|
|||||
|
2021
Q3 | $447K | Sell |
|
|||||
|
2021
Q2 | $538K | Sell |
|
|||||
|
2021
Q1 | $612K | Buy |
|
|||||
|
2020
Q4 | $420K | Sell |
|
|||||
|
2020
Q3 | $439K | Buy |
|
|||||
|
2020
Q2 | $241K | Buy |
|
|||||
|
2020
Q1 | $222K | Sell |
|
|||||
|
2019
Q4 | $1.98M | Buy |
|
|||||
|
2019
Q3 | $371K | Buy |
|
|||||
|
2019
Q2 | $423K | Buy |
|
|||||
|
2019
Q1 | $486K | Buy |
|
|||||
|
2018
Q4 | $549K | Sell |
|
|||||
|
2018
Q3 | $623K | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $1.72M | Buy |
|
|||||
|
2017
Q4 | $1.18M | Buy |
|